Empire Bluecross policy updates
Track new and updated Empire Bluecross policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Facility Guidelines for Claims Related to Professional Services | Empire Bluecross | Reimbursement | — | Modified | Dec 1, 2026 |
| Avlayah (tividenofusp alfa-eknm) Coverage for Neurologic Manifestations of MPS II | Empire Bluecross | Clinical | Pharmacy & Specialty Drugs | Modified | Oct 27, 2026 |
| Rybrevant (amivantamab-vmjw), Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) | Empire Bluecross | Clinical | Pharmacy & Specialty Drugs | Modified | Oct 27, 2026 |
| Tevimbra (tislelizumab-jsgr) Coverage and Prior Authorization | Empire Bluecross | Clinical | Pharmacy & Specialty Drugs | Modified | Oct 27, 2026 |
| Facility Guidelines for Claims Related to Professional Services - Facility | Empire Bluecross | Reimbursement | Post-Acute & Facility Care | Modified | Oct 1, 2026 |
| Levoleucovorin and Leucovorin Agents | Empire Bluecross | Clinical | Pharmacy & Specialty Drugs | Modified | Sep 18, 2026 |
| Opdivo Qvantig (nivolumab hyaluronidase-nvhy) Coverage Criteria | Empire Bluecross | Clinical | Pharmacy & Specialty Drugs | Modified | Sep 18, 2026 |
| Saphnelo (anifrolumab-fnia) for systemic lupus erythematosus | Empire Bluecross | Clinical | Pharmacy & Specialty Drugs | Modified | Sep 18, 2026 |
| Vascular Endothelial Growth Factor (VEGF) Inhibitors | Empire Bluecross | Clinical | Pharmacy & Specialty Drugs | Modified | Sep 18, 2026 |
| Yartemlea (narsoplimab-wuug) | Empire Bluecross | Clinical | Pharmacy & Specialty Drugs | Modified | Sep 18, 2026 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.